1.
The Characteristics of Cardiovascular Adverse Events in Therapy with Immune Checkpoint Inhibitors: The Result of Work of the Multi-Disciplinary Team. Вопр. онкол. [Internet]. 2024 Jul. 4 [cited 2026 Oct. 14];70(3):541-9. Available from: http://voprosyonkologii.ru/index.php/journal/article/view/3-24-The-Characteristics